DexCom, Inc. today announced that it plans to release its first quarter 2024 financial results after market close on Thursday, April 25, 2024. Management will hold a conference call to review the.
Perfromance Wealth Partners LLC cut its stake in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 6.7% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 37,087 shares of the medical device company’s stock after selling 2,664 shares during the quarter. Perfromance […]
DexCom Inc. NASDAQ: DXCM is a leading medical device company in the medical sector that specializes in continuous glucose monitoring (CGM) systems. People…
02.04.2024 - DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its first quarter 2024 financial results after market close on Thursday, April 25, 2024. Management will hold a conference call to review the company s first quarter 2024 .
Pinnacle Financial Partners Inc trimmed its position in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 6.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 49,822 shares of the medical device company’s stock after selling 3,159 shares during […]